Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients
Tullio Palmerini(University of Bologna), Gregg W. Stone(Cardiovascular Institute of the South), Philippe Généreux(Morristown Medical Center), Yangsoo Jang(Yonsei University), Deepak L. Bhatt(Mount Sinai Hospital), Umberto Benedetto(University of Oxford), Martine Gilard(Hôpital Maison Blanche), Alaide Chieffo, Antonio Colombo(Humanitas University), Marco Valgimigli(University of Bern), Maria Pufulete(University of Bristol), Alexandre Abizaid(Universidade de São Paulo), Diego Sangiorgi(University of Bologna), Hyo‐Soo Kim(Inje University Ilsan Paik Hospital), Myeong‐Ki Hong(Yonsei University), Gianni D. Angelini(Bristol Royal Infirmary), Giuseppe Biondi‐Zoccai(Maria Cecilia Hospital), Diego Della Riva(University of Bologna), Fausto Feres(Instituto Dante Pazzanese de Cardiologia), Maria Letizia Bacchi Reggiani, Marie‐Claude Morice(Cardiovascular European Research Center), Kyung Woo Park(Seoul National University Hospital), Jonathon White(NewYork–Presbyterian Hospital), Byeong‐Keuk Kim(Yonsei University)
Cited by 200
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k